News Daily News No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows Todd Neale December 29, 2022
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women L.A. McKeown November 21, 2022
News Conference News AHA 2022 Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START Todd Neale November 14, 2022
News Conference News AHA 2022 Sizeable Minority of Pregnant Women Have CVD, US Data Show Caitlin E. Cox November 11, 2022
News Daily News Anatomic Features Key for Selecting Patients Best Suited to PFO Closure Yael L. Maxwell October 14, 2022
News Conference News HFSA 2022 No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3 Yael L. Maxwell October 07, 2022
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Conference News TCT 2022 PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope Todd Neale September 17, 2022
News Daily News Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI Yael L. Maxwell September 08, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2022 Shelley Wood September 01, 2022
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit Todd Neale August 17, 2022
News Daily News Peridevice Leaks After LAA Occlusion Signal Poorer 5-Year Outcomes Todd Neale July 28, 2022
News Conference News TVT 2022 More Support for Single Antiplatelet Therapy After TAVI Michael O'Riordan June 10, 2022